Low-Dose Aspirin to Prevent Preeclampsia in Pregnancy
Aulia Berliana
Abstract
Background. To date, an effective screening algorithm for the identification of women at risk of developing preeclampsia does not yet exist, so prevention of preeclampsia is an important component of prenatal care. Meanwhile, giving low-dose aspirin to pregnant women is thought to prevent preeclampsia in pregnancy. So the aim of this literature review is to determine the effect of aspirin therapy to prevent preeclampsia in pregnancy. Method. This study is a literature review, with the literature used involving as many as 21 of the results literature. Several studies have shown that the effect of low-dose aspirin therapy can significantly reduce the development of preeclampsia, reduce the incidence of preterm birth and small for gestational age significantly. Conclusion. Treatment with low-dose aspirin in women at high risk for preeclampsia resulted in a lower incidence compared with placebo.
Downloads
References
Ahrens, K. A., Silver, R. M., Mumford, S. L., Sjaarda, L. A., Perkins, N. J., Wactawski-Wende, J., Galai, N., Townsend, J. M., Lynch, A. M., Lesher, L. L., Faraggi, D., Zarek, S., & Schisterman, E. F. (2016). Complications and safety of preconception low-dose aspirin among women with prior pregnancy losses. Obstetrics and Gynecology, 127(4), 689–698. https://doi.org/10.1097/AOG.0000000000001301
Amaral, L. M., Wallace, K., Owens, M., & LaMarca, B. (2017). Pathophysiology and Current Clinical Management of Preeclampsia. Current Hypertension Reports, 19(8), 19–21. https://doi.org/10.1007/s11906-017-0757-7
Andrikopoulou, M., Purisch, S. E., Handal-Orefice, R., & Gyamfi-Bannerman, C. (2018). Low-dose aspirin is associated with reduced spontaneous preterm birth in nulliparous women. American Journal of Obstetrics and Gynecology, 219(4), 399.e1-399.e6. https://doi.org/10.1016/j.ajog.2018.06.011
Anto, E. O., Owiredu, W. K. B. A., Sakyi, S. A., Turpin, C. A., Ephraim, R. K. D., Fondjo, L. A., Obirikorang, C., Adua, E., & Acheampong, E. (2018). Adverse pregnancy outcomes and imbalance in angiogenic growth mediators and oxidative stress biomarkers is associated with advanced maternal age births: A prospective cohort study in Ghana. PLoS ONE, 13(7), 1–12. https://doi.org/10.1371/journal.pone.0200581
Costa, F., Panaodage, S., & Brennecke, S. (2013). Low dose aspirin improve trophoblastic function in early-onset pre-eclampsia. Ultrasound in Obstetrics & Gynecology, 42(Suppl.1), 1–47.
Dixon, C. L., Marrs, C., Costantine, M. M., Pacheco, L. D., Saade, G. R., & Chiossi, G. (2017). Effect of Low-Dose Aspirin on the Time of Onset of Preeclampsia and Time of Delivery. American Journal of Perinatology, 34(12), 1219–1226.
https://doi.org/10.1055/s-0037-1602421
Dutta, S., Kumar, S., Hyett, J., & Salomon, C. (2019). Molecular targets of aspirin and prevention of preeclampsia and their potential association with circulating extracellular vesicles during pregnancy. International Journal of Molecular Sciences, 20(18). https://doi.org/10.3390/ijms20184370
Erlandsson, L., Ducat, A., Castille, J., Zia, I., Kalapotharakos, G., Hedström, E., Vilotte, J. L., Vaiman, D., & Hansson, S. R. (2019). Alpha-1 microglobulin as a potential therapeutic candidate for treatment of hypertension and oxidative stress in the STOX1 preeclampsia mouse model. Scientific Reports, 9(1), 1–13.
https://doi.org/10.1038/s41598-019-44639-9
Fantasia, H. C. (2018). Low-Dose Aspirin for the Prevention of Preeclampsia. Nursing for Women’s Health, 22(1), 87–92. https://doi.org/10.1016/j.nwh.2017.12.002
Founds, S. A., Conley, Y. P., Lyons-Weiler, J. F., Jeyabalan, A., Allen Hogge, W., & Conrad, K. P. (2009). Altered Global Gene Expression in First Trimester Placentas of Women Destined to Develop Preeclampsia. Placenta, 30(1), 15–24.
https://doi.org/10.1016/j.placenta.2008.09.015
Gil-Villa, A. M., Norling, L. V., Serhan, C. N., Cordero, D., Rojas, M., & Cadavid, A. (2012). Aspirin triggered-lipoxin A4 reduces the adhesion of human polymorphonuclear neutrophils to endothelial cells initiated by preeclamptic plasma. Prostaglandins Leukotrienes and Essential Fatty Acids, 87(4–5), 127–134.
https://doi.org/10.1016/j.plefa.2012.08.003
Grotegut, C. A. (2016). Prevention of preeclampsia Find the latest version : Prevention of preeclampsia. The Journal of Clinical Investigation, 126(12), 4396–4398.
https://doi.org/10.1172/JCI91300.As
Halscott, T. L., Ramsey, P. S., & Reddy, U. M. (2014). First trimester screening cannot predict adverse outcomes yet. Prenatal Diagnosis, 34(7), 668–676.
https://doi.org/10.1002/pd.4407
Khairunnisa, L. (2020). Dark Chocolate Consumption to Prevent Preeclampsia. Jurnal Ilmiah Kesehatan Sandi Husada, 11(1), 517–521.
https://doi.org/10.35816/jiskh.v10i2.341
Li, C., Raikwar, N. S., Santillan, M. K., Santillan, D. A., & Thomas, C. P. (2015). Aspirin inhibits expression of sFLT1 from human cytotrophoblasts induced by hypoxia, via cyclo-oxygenase 1. Placenta, 36(4), 446–453.
https://doi.org/10.1016/j.placenta.2015.01.004
Mendes, S., Timóteo-Ferreira, F., Almeida, H., & Silva, E. (2019). New insights into the process of placentation and the role of oxidative uterine microenvironment. Oxidative Medicine and Cellular Longevity, 2019.
https://doi.org/10.1155/2019/9174521
Moore, G. S., Allshouse, A. A., Post, A. L., Galan, H. L., & Heyborne, K. D. (2015). Early initiation of low-dose aspirin for reduction in preeclampsia risk in high-risk women: A secondary analysis of the MFMU High-Risk Aspirin Study. Journal of Perinatology, 35(5), 328–331. https://doi.org/10.1038/jp.2014.214
Navaratnam, K., Alfirevic, A., & Alfirevic, Z. (2016). Low dose aspirin and pregnancy: how important is aspirin resistance? BJOG: An International Journal of Obstetrics and Gynaecology, 123(9), 1481–1487. https://doi.org/10.1111/1471-0528.13914
Odibo, A. O., Goetzinger, K. R., Odibo, L., & Tuuli, M. G. (2015). Early prediction and aspirin for the prevention of pre-eclampsia (EPAPP) study: A randomized controlled trial. Ultrasound in Obstetrics and Gynecology, 46(4), 414–418.
https://doi.org/10.1002/uog.14889
Panagodage, S., Yong, H. E. J., Da Silva Costa, F., Borg, A. J., Kalionis, B., Brennecke, S. P., & Murthi, P. (2016). Low-Dose Acetylsalicylic Acid Treatment Modulates the Production of Cytokines and Improves Trophoblast Function in an In Vitro Model of Early-Onset Preeclampsia. American Journal of Pathology, 186(12), 3217–3224. https://doi.org/10.1016/j.ajpath.2016.08.010
Perneby, C., Vahter, M., Åkesson, A., Bremme, K., & Hjemdahl, P. (2011). Thromboxane metabolite excretion during pregnancy - Influence of preeclampsia and aspirin treatment. Thrombosis Research, 127(6), 605–606.
https://doi.org/10.1016/j.thromres.2011.01.005
Rolnik, D. L., Wright, D., Poon, L. C., O’Gorman, N., Syngelaki, A., De Paco Matallana, C., Akolekar, R., Cicero, S., Janga, D., Singh, M., Molina, F. S., Persico, N., Jani, J. C., Plasencia, W., Papaioannou, G., Tenenbaum-Gavish, K., Meiri, H., Gizurarson, S., Maclagan, K., & Nicolaides, K. H. (2017). Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. New England Journal of Medicine, 377(7), 613–622. https://doi.org/10.1056/NEJMoa1704559
Villa, P. M., Kajantie, E., Räikkönen, K., Pesonen, A. K., Hämäläinen, E., Vainio, M., Taipale, P., & Laivuori, H. (2013). Aspirin in the prevention of pre-eclampsia in high-risk women: A randomized placebo-controlled PREDO Trial and a meta-analysis of randomized trials. BJOG: An International Journal of Obstetrics and Gynaecology,20(1), 64–74.
3.png){kind=logo}
